Annual EBITDA:
-$141.87M-$37.28M(-35.65%)Summary
- As of today, OLMA annual EBITDA is -$141.87 million, with the most recent change of -$37.28 million (-35.65%) on December 31, 2024.
- During the last 3 years, OLMA annual EBITDA has fallen by -$70.54 million (-98.89%).
- OLMA annual EBITDA is now -6464.78% below its all-time high of -$2.16 million, reached on December 31, 2018.
Performance
OLMA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$47.73M-$12.99M(-37.38%)Summary
- As of today, OLMA quarterly EBITDA is -$47.73 million, with the most recent change of -$12.99 million (-37.38%) on June 30, 2025.
- Over the past year, OLMA quarterly EBITDA has dropped by -$14.30 million (-42.76%).
- OLMA quarterly EBITDA is now -4607.30% below its all-time high of -$1.01 million, reached on December 31, 2019.
Performance
OLMA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$156.66M-$14.30M(-10.04%)Summary
- As of today, OLMA TTM EBITDA is -$156.66 million, with the most recent change of -$14.30 million (-10.04%) on June 30, 2025.
- Over the past year, OLMA TTM EBITDA has dropped by -$35.39 million (-29.18%).
- OLMA TTM EBITDA is now -15349.21% below its all-time high of -$1.01 million, reached on December 31, 2019.
Performance
OLMA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OLMA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -35.6% | -42.8% | -29.2% |
| 3Y3 Years | -98.9% | -45.2% | -67.3% |
| 5Y5 Years | -3193.8% | -1821.6% | -1163.0% |
OLMA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -98.9% | at low | -125.4% | at low | -58.7% | at low |
| 5Y | 5-Year | -3193.8% | at low | -506.8% | at low | -1163.0% | at low |
| All-Time | All-Time | -6464.8% | at low | -4607.3% | at low | >-9999.0% | at low |
OLMA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$47.73M(-37.4%) | -$156.66M(-10.0%) |
| Mar 2025 | - | -$34.74M(+5.2%) | -$142.36M(-0.3%) |
| Dec 2024 | -$141.87M(-35.6%) | -$36.65M(+2.3%) | -$141.87M(-4.7%) |
| Sep 2024 | - | -$37.53M(-12.2%) | -$135.54M(-11.8%) |
| Jun 2024 | - | -$33.44M(+2.4%) | -$121.27M(-11.2%) |
| Mar 2024 | - | -$34.25M(-12.9%) | -$109.01M(-4.9%) |
| Dec 2023 | -$104.58M(+1.9%) | -$30.33M(-30.4%) | -$103.93M(-3.5%) |
| Sep 2023 | - | -$23.25M(-9.8%) | -$100.40M(-0.4%) |
| Jun 2023 | - | -$21.18M(+27.4%) | -$99.95M(+10.5%) |
| Mar 2023 | - | -$29.18M(-8.9%) | -$111.66M(-6.0%) |
| Dec 2022 | -$106.63M | -$26.80M(-17.5%) | -$105.33M(-6.7%) |
| Sep 2022 | - | -$22.80M(+30.7%) | -$98.72M(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$32.88M(-43.9%) | -$93.63M(-21.2%) |
| Mar 2022 | - | -$22.85M(-13.2%) | -$77.23M(-10.6%) |
| Dec 2021 | -$71.33M(-232.4%) | -$20.18M(-14.0%) | -$69.83M(-16.8%) |
| Sep 2021 | - | -$17.71M(-7.4%) | -$59.77M(-19.7%) |
| Jun 2021 | - | -$16.49M(-6.8%) | -$49.92M(-39.0%) |
| Mar 2021 | - | -$15.44M(-52.5%) | -$35.92M(-66.9%) |
| Dec 2020 | -$21.46M(-398.2%) | -$10.13M(-28.7%) | -$21.52M(-73.5%) |
| Sep 2020 | - | -$7.87M(-216.7%) | -$12.40M(-173.3%) |
| Jun 2020 | - | -$2.48M(-138.8%) | -$4.54M(-120.9%) |
| Mar 2020 | - | -$1.04M(-2.6%) | -$2.05M(-102.6%) |
| Dec 2019 | -$4.31M(-99.3%) | -$1.01M | -$1.01M |
| Dec 2018 | -$2.16M | - | - |
FAQ
- What is Olema Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Olema Pharmaceuticals, Inc.?
- What is Olema Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Olema Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Olema Pharmaceuticals, Inc.?
- What is Olema Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Olema Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Olema Pharmaceuticals, Inc.?
- What is Olema Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Olema Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of OLMA is -$141.87M
What is the all-time high annual EBITDA for Olema Pharmaceuticals, Inc.?
Olema Pharmaceuticals, Inc. all-time high annual EBITDA is -$2.16M
What is Olema Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, OLMA annual EBITDA has changed by -$37.28M (-35.65%)
What is Olema Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of OLMA is -$47.73M
What is the all-time high quarterly EBITDA for Olema Pharmaceuticals, Inc.?
Olema Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$1.01M
What is Olema Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, OLMA quarterly EBITDA has changed by -$14.30M (-42.76%)
What is Olema Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of OLMA is -$156.66M
What is the all-time high TTM EBITDA for Olema Pharmaceuticals, Inc.?
Olema Pharmaceuticals, Inc. all-time high TTM EBITDA is -$1.01M
What is Olema Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, OLMA TTM EBITDA has changed by -$35.39M (-29.18%)